المؤلفون: van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Saratsis AM; Department of Neurosurgery, Advocate Children's Hospital, Park Ridge, Illinois, USA., Geurts M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Franceschi E; Department of Nervous System Medical Oncology, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

المصدر: Neuro-oncology [Neuro Oncol] 2024 May 03; Vol. 26 (Supplement_2), pp. S110-S124.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Diffuse Intrinsic Pontine Glioma*/therapy , Diffuse Intrinsic Pontine Glioma*/genetics , Diffuse Intrinsic Pontine Glioma*/pathology , Glioma*/genetics , Glioma*/therapy , Glioma*/pathology , Histones*/genetics , Mutation*, Humans ; Brain Neoplasms/therapy ; Brain Neoplasms/genetics ; Brain Neoplasms/pathology ; Brain Stem Neoplasms/therapy ; Brain Stem Neoplasms/genetics ; Brain Stem Neoplasms/pathology ; Prognosis

المؤلفون: Wang X; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Liu H; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Fei Y; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Song Z; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Meng X; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Yu J; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Liu X; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Li L; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Qiu L; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Qian Z; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Zhou S; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Wang X; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China., Zhang H; National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine and Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.

المصدر: Hematological oncology [Hematol Oncol] 2024 Jul; Vol. 42 (4), pp. e3279.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/metabolism , Lymphoma, Large B-Cell, Diffuse*/pathology , Lymphoma, Large B-Cell, Diffuse*/genetics , Lymphoma, Large B-Cell, Diffuse*/mortality , Tumor Microenvironment* , Metabolic Networks and Pathways*, Humans ; Prognosis ; Biomarkers, Tumor/metabolism ; Female ; Male ; Gene Expression Profiling ; Mutation

المؤلفون: Sinkarevs S; Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia., Strumfs B; Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia., Volkova S; Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia., Strumfa I; Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.

المصدر: Cells [Cells] 2024 Jun 18; Vol. 13 (12). Date of Electronic Publication: 2024 Jun 18.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Lymphoma, Large B-Cell, Diffuse*/pathology , Lymphoma, Large B-Cell, Diffuse*/immunology, Humans ; Animals ; Myeloid-Derived Suppressor Cells/pathology ; Myeloid-Derived Suppressor Cells/immunology

المؤلفون: Yan Z, Zhong Q, Yan L; The First Affiliated Hospital of Gannan Medical University, Department of Ultrasonography, Ganzhou, 341000, China., Lai W; The First Affiliated Hospital of Gannan Medical University, Department of Hematology, Ganzhou, 341000, China., Xu X; The First Affiliated Hospital of Gannan Medical University, Department of Hematology, Ganzhou, 341000, China.

المصدر: Journal of applied biomedicine [J Appl Biomed] 2024 Jun; Vol. 22 (2), pp. 107-114. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Sp z.o.o Country of Publication: Poland NLM ID: 101221755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1214-0287 (Electronic) Linking ISSN: 1214021X NLM ISO Abbreviation: J Appl Biomed Subsets: MEDLINE

مواضيع طبية MeSH: Pyruvates*/pharmacology , Pyruvates*/therapeutic use , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/pathology , Cell Adhesion*/drug effects , Cell Proliferation*/drug effects, Humans ; Animals ; Cell Line, Tumor ; Mice ; Apoptosis/drug effects ; Proto-Oncogene Proteins c-jun/metabolism ; Proto-Oncogene Proteins c-jun/genetics ; Xenograft Model Antitumor Assays

المؤلفون: Ide D; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Egashira A; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Miyashita A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Mizuhara K; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Isa R; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Uchiyama H; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Kaneko H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Kawata E; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan., Taniwaki M; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Blood Transfusion, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. junkuro@koto.kpu-m.ac.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 697-706. Date of Electronic Publication: 2024 Mar 16.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/therapy , Lymphoma, Large B-Cell, Diffuse*/blood , Lymphoma, Large B-Cell, Diffuse*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/mortality , Monocytes* , Lymphocytes*/pathology, Humans ; Aged ; Male ; Female ; Retrospective Studies ; Middle Aged ; Prognosis ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Rituximab/administration & dosage ; Rituximab/therapeutic use ; Doxorubicin/administration & dosage ; Doxorubicin/therapeutic use ; Recurrence ; Prednisone/administration & dosage ; Prednisone/therapeutic use ; Adult ; Vincristine/administration & dosage ; Vincristine/therapeutic use

المؤلفون: Gozlan EC; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, U.S.A., Huda TI; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, U.S.A., Quach JU; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, U.S.A., Varkhedi M; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, U.S.A., Desantis JE; Research Computing, University of South Florida, Tampa, FL, U.S.A., Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, U.S.A.; gblanck@usf.edu.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.

المصدر: Anticancer research [Anticancer Res] 2024 Jun; Vol. 44 (6), pp. 2325-2333.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Brain Stem Neoplasms*/genetics , Brain Stem Neoplasms*/microbiology , Brain Stem Neoplasms*/pathology , Diffuse Intrinsic Pontine Glioma*/genetics , Diffuse Intrinsic Pontine Glioma*/microbiology , Diffuse Intrinsic Pontine Glioma*/pathology, Humans ; Male ; Disease Progression ; Child ; Immunoglobulins/genetics ; Female ; Child, Preschool ; Lymphocytes, Tumor-Infiltrating/immunology

المؤلفون: Sciarra R; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Merli M; Division of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy., Cristinelli C; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Lucioni M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Anatomic Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Zibellini S; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Riboni R; Anatomic Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Furlan D; Anatomic Pathology Unit, University of Insubria, Ospedale di Circolo, Varese, Italy., Uccella S; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Pathology Service, IRCCS, Humanitas Research Hospital, Milan, Italy., Zerbi C; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Bianchi B; Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, Varese, Italy., Gotti M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Ferretti VV; Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Varraso C; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Fraticelli S; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Anatomic Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Lazic T; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Defrancesco I; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Medical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy., Mora B; Division of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy., Libera L; Anatomic Pathology Unit, University of Insubria, Ospedale di Circolo, Varese, Italy., Mazzacane A; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Carpi F; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Berliner M; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Neri G; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Rizzo E; enGenome s.r.l., Pavia, Italy., De Paoli F; enGenome s.r.l., Pavia, Italy., Sessa F; Anatomic Pathology Unit, University of Insubria, Ospedale di Circolo, Varese, Italy., Passamonti F; Division of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.; University of Milan, Milan, Italy., Paulli M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Anatomic Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Arcaini L; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

المصدر: British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2242-2253. Date of Electronic Publication: 2024 Mar 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/genetics , Lymphoma, Large B-Cell, Diffuse*/virology , Hepatitis C*/complications , Hepatitis C*/genetics , Mutation*, Humans ; Male ; Aged ; Female ; Middle Aged ; Aged, 80 and over ; Hepacivirus/genetics ; Adult ; High-Throughput Nucleotide Sequencing

المؤلفون: Tan J; Department of Hematology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China., Zhong J; Department of Hematology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China., Hu W; Department of Hematology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China., Wu G; Department of Pathology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China., Zeng C; Medical Research Center, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China., Xiong D; Department of Hematology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.

المصدر: The Journal of international medical research [J Int Med Res] 2024 Jun; Vol. 52 (6), pp. 3000605241258597.

نوع المنشور: Journal Article; Case Reports; Review

بيانات الدورية: Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE

مواضيع طبية MeSH: Brentuximab Vedotin*/therapeutic use , Transplantation, Autologous* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Lymphoma, Large B-Cell, Diffuse*/therapy , Lymphoma, Large B-Cell, Diffuse*/pathology , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Doxorubicin*/therapeutic use , Doxorubicin*/administration & dosage, Humans ; Female ; Aged ; Peripheral Blood Stem Cell Transplantation/methods ; Rituximab/therapeutic use ; Rituximab/administration & dosage ; Prednisone/therapeutic use ; Prednisone/administration & dosage ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/administration & dosage ; Lenalidomide/therapeutic use ; Lenalidomide/administration & dosage ; Lymphoma, B-Cell, Marginal Zone/drug therapy ; Lymphoma, B-Cell, Marginal Zone/therapy ; Lymphoma, B-Cell, Marginal Zone/pathology ; Lymphoma, B-Cell, Marginal Zone/surgery ; Combined Modality Therapy

المؤلفون: Akiyoshi M; Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Azabu University, Sagamihara City, Kanagawa, Japan.; Akiyoshi Animal Clinic, Yamato City, Kanagawa, Japan., Hisasue M; Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Azabu University, Sagamihara City, Kanagawa, Japan., Goto-Koshino Y; Molecular Diagnostic Laboratory, Veterinary Medical Center, The University of Tokyo, Tokyo, Japan.; Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan., Asakawa MG; Clinical and Anatomic Pathology Unit, Veterinary Specialists Emergency Center, Kawaguchi City, Saitama, Japan., Neo S; Laboratory of Clinical Diagnosis, Azabu University, Sagamihara City, Kanagawa, Japan., Akiyoshi M; Akiyoshi Animal Clinic, Yamato City, Kanagawa, Japan., Tomiyasu H; Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.

المصدر: Veterinary clinical pathology [Vet Clin Pathol] 2024 Jun; Vol. 53 (2), pp. 234-241. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: American Society for Veterinary Clinical Pathology Country of Publication: United States NLM ID: 9880575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-165X (Electronic) Linking ISSN: 02756382 NLM ISO Abbreviation: Vet Clin Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Dog Diseases*/pathology , Dog Diseases*/diagnosis , Splenic Neoplasms*/veterinary , Splenic Neoplasms*/pathology , Lymphoma, B-Cell, Marginal Zone*/veterinary , Lymphoma, B-Cell, Marginal Zone*/pathology , Lymphoma, Large B-Cell, Diffuse*/veterinary , Lymphoma, Large B-Cell, Diffuse*/pathology , Lymphoma, Large B-Cell, Diffuse*/diagnosis, Animals ; Dogs ; Female ; Gallbladder Neoplasms/veterinary ; Gallbladder Neoplasms/pathology ; Gallbladder/pathology

المؤلفون: Li W; Department of Oncology, Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China., Gao M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China., Xue W; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China., Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China., Chang Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China., Zhang K; Department of Oncology, Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China., Wen C; Department of Oncology, Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China., Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China. Electronic address: zhangmingzhi2z518@163.com.

المصدر: Chinese journal of natural medicines [Chin J Nat Med] 2024 Jun; Vol. 22 (6), pp. 554-567.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Science Press Country of Publication: China NLM ID: 101504416 Publication Model: Print Cited Medium: Internet ISSN: 1875-5364 (Electronic) Linking ISSN: 18755364 NLM ISO Abbreviation: Chin J Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: MicroRNAs*/genetics , MicroRNAs*/metabolism , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/genetics , Lymphoma, Large B-Cell, Diffuse*/metabolism , Forkhead Box Protein O1*/genetics , Forkhead Box Protein O1*/metabolism , DNA Methyltransferase 3A* , Palmitic Acid*/pharmacology, Humans ; Animals ; Mice ; Cell Line, Tumor ; DNA Methylation/drug effects ; DNA (Cytosine-5-)-Methyltransferases/genetics ; DNA (Cytosine-5-)-Methyltransferases/metabolism ; Promoter Regions, Genetic/drug effects ; Mice, Nude ; Male ; Gene Expression Regulation, Neoplastic/drug effects ; Female ; Apoptosis/drug effects ; Autophagy/drug effects ; Mice, Inbred BALB C